Managing bleeds on anticoagulant therapy: a practical guide for clinicians

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Bleeding is a common and serious complication of oral anticoagulant therapy.
• Patients with conditions like atrial fibrillation face increased bleeding risk, impacting morbidity and mortality.
• Discontinuation of anticoagulation post-bleeding can lead to subsequent ischemic events.

Purpose of the Study:

• To review the epidemiology and clinical impact of bleeding in patients on oral anticoagulants.
• To provide patient-centered flowcharts for managing acute bleeding and resuming anticoagulation.
• To highlight areas for future research in optimizing anticoagulant therapy and patient safety.

Main Methods:

• Literature review focusing on bleeding complications in oral anticoagulant therapy.
• Synthesis of epidemiological data and clinical impact assessments.
• Development of evidence-based management and treatment resumption flowcharts.

Main Results:

• Oral anticoagulants, while vital for preventing thrombotic events, significantly elevate bleeding risks.
• Bleeding events have long-term consequences, including effects on treatment adherence and future ischemic event risk.
• Effective management requires balancing thrombotic and bleeding risks through stratification, prevention, and timely intervention.

Conclusions:

• Optimizing the balance between preventing thrombosis and managing bleeding is crucial for patients on oral anticoagulants.
• Contemporary management strategies and clear guidelines for anticoagulation resumption are essential.
• Future research should prioritize improved risk prediction, personalized regimens, and accessible reversal agents.